Akèy › Kansè (tout kalite) › Maryland › Baltimore
Etid klinik pou Kansè (tout kalite) nan Baltimore, MD
37 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Ap rekriteFaz 2
- Greater Baltimore Medical Center ( Site 1104), Baltimore
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
- Chesapeake Urology, Baltimore
- Johns Hopkins Medical Center, Baltimore
Registry Study for Radiation Therapy Outcomes
Ap rekriteEtid obsèvasyon
- Maryland Proton Treatment Center, Baltimore
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Ap rekriteFaz 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- ak 1 plis
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Ap rekriteFaz 3
- University of Maryland Medical System - University of Maryland Medical Center, Baltimore
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
- Quetzal Site 23, Baltimore
Prospective Study to Assess a Diagnostic Aid for Cancer
Ap rekriteEtid obsèvasyon
- Velocity Clinical Research, Annapolis · 22 mi lwen
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore
- Sidney Kimmel Comp Cancer Center at Johns Hopkins, Baltimore
Collection of Tissue Samples for Cancer Research
Ap rekriteEtid obsèvasyon
- Johns Hopkins University, Baltimore
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Sheppard Pratt, Towson · 8 mi lwen
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Baltimore
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Johns Hopkins Bayview Medical Center, Baltimore
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Ap rekriteEtid obsèvasyon
- University of Maryland, Baltimore
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Ap rekriteFaz 3
- Johns Hopkins, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Ap rekriteFaz 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
EXoPERT EMERALD Clinical Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- John Hopkins University, Baltimore
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Ap rekriteEtid obsèvasyon
- Johns Hopkins University, Baltimore
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Ap rekriteFaz 2
- University of Maryland, Baltimore, Baltimore
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Ap rekriteFaz 1
- Johns Hopkins Hospital /ID# 254056, Baltimore
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Ap rekrite
- Luana Colloca, Baltimore
- University of Maryland, Baltimore
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Ap rekriteFaz 2
- University of Maryland Medical Center, Baltimore
Primary Tumor Research and Outcomes Network
Ap rekriteEtid obsèvasyon
- Johns Hopkins University School of Medicine, Baltimore
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- University of Maryland, Baltimore
- Johns Hopkins University, Baltimore
Caris Biorepository Research Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Ap rekriteFaz 1
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi lwen
HP Pyruvate MRI in Cancers
Ap rekriteFaz 1/2
- University of Maryland Medical Center, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Ap rekriteEtid obsèvasyon
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · 22 mi lwen
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Ap rekriteEtid obsèvasyon
- University of Maryland Medical Center, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Ap rekriteFaz 1/2
- Johns Hopkins, Baltimore
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- MedStar Franklin Square Medical Center, Baltimore
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
- Kansè ovè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.